The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures
Petr Scholle, Štěpán Wenke, Tereza Nekovářová, Yulia Zaytseva, Filip Tylš, Martin Brunovský, Jiřı́ Horáček, Veronika Andrashko, Vlastimil Koudelka, Michaela Viktorinová, Vojtěch Viktorin, Kateřina Hájková, Martin Kuchař, Tomáš Páleníček
Journal of Psychopharmacology 2026 DOI: 10.1177/02698811251389552 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Double-blinded placebo-controlled study Peer reviewed |
|---|---|
| Sample size | 24 |
| Population | Healthy volunteers |
| Intervention | Psilocybin |
| Topics | Psilocybin Serotonin |
| Keywords | Hallucinogen Time perception Cognitive psychology Audiology Cognition Placebo Rating scale Developmental psychology Expectancy theory |
| Citations | 1 |
| Key points | Psilocybin caused a rightward shift in the bisection point and increased the just noticeable difference, indicating subjective time slowing and decreased temporal precision. |
Abstract
Background: Although psychedelics have regained attention as potential treatment tools for various mental disorders, little research has examined their impact on temporal perception.
Aims: This double-blinded placebo-controlled study aimed to investigate changes in temporal perception under psilocybin, both through performance during the Temporal Bisection Task (TBT) and through subjective self-report scales.
Methods: Twenty-four healthy volunteers were assessed by comparing their performance on two parameters of the TBT —the Bisection Point (BP) and the Just Noticeable Difference (JND) with subjectively reported changes measured using the Hallucinogen Rating Scale (HRS) and the Altered States of Consciousness (ASC) questionnaires.
Results: We observed a rightward shift in BP under psilocybin compared to placebo ( t (23) = 2.27, p = 0.033, g = −0.37). This shift corresponded to reports of subjective time slowing down under psilocybin as measured by HRS and ASC. Psilocybin also increased JND compared to placebo ( t (23) = 2.48, p = 0.021, g = −0.47), indicating decreased temporal precision. Consistent with previous findings, these effects were significant for durations longer than 2 seconds.
Conclusions: Based on Bayesian framework of timing, we emphasised that psilocybin alters time perception through disruptions in cognitive functions, particularly working memory and attention. We also outlined directions for future research, which would allow us to not only understand time perception under psychedelics better, but help elucidate the role of serotonergic system on timing. Research ID: The research was conducted as part of a clinical trial registered at EudraCT database under the number 2012-004579-37.
Comparable studies
Other randomized controlled trials on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety | 2016 | Randomized controlled trial | n = 51 |
| Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression | 2016 | Double-blind, placebo-controlled, crossover trial | n = 29 |
| Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... | 2006 | Double-blind study | n = 36 |
| Trial of Psilocybin versus Escitalopram for Depression Selected group of patients with depression | 2021 | Randomized controlled trial | |
| Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder Adults aged 21 to 75 years with major depressive disorder, not currently using... | 2020 | Randomized controlled trial | n = 24 |
Citations in the library
Cited by 2
- Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex. European Journal of Neuroscience June 1, 2026
- Investigation of the pharmacological and circuit basis for psychedelic drug effects on interval timing in mice. Psychopharmacology October 19, 2026
Cites 28
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs Frontiers in Human Neuroscience 2014
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics Pharmacological Reviews June 20, 2019
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport December 1, 1998
- The Predictive Coding Account of Psychosis. Biological Psychiatry May 25, 2018
and 23 more in the library